HeartBeam has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...

The Cardiospy analysis software provides ECG records of excellent quality. With the EC-12H Holter recorder you can make 1, 2, 3 or 12 channel recordings depending on the recorder and patient cable ...

AliveCor announced that CMS included its AI-powered ECG system in a final rule that sets a Medicare payment rate for the ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...

Kardia 12L performed comparably to the standard 12-lead ECG in detecting major morphology-related abnormalities. "AliveCor's Kardia 12L ECG System was born from our vision to leverage AI and ...

This approval enables hospital outpatient settings to receive a Medicare payment rate of $59.40 when the FDA-cleared Kardia™ 12L ECG System is used to perform 12-lead ECGs. "Cardiovascular ...

HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

An artificial intelligence (AI) model designed to predict a person's biological age (age of body cells and tissues) based on electrocardiogram (ECG) data found a strong association between ECG-age and ...

The Company believes the study's findings support the clinical equivalence of HeartBeam's synthesized 12-lead ECG where the leads are similar to standard 12-lead ECGs for rhythm and arrhythmia ...